"Receptors, Dopamine D4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of dopamine D2 receptors that has high affinity for the antipsychotic CLOZAPINE.
| Descriptor ID |
D050638
|
| MeSH Number(s) |
D12.776.543.750.670.300.400.500.500 D12.776.543.750.695.150.400.500.750 D12.776.543.750.720.330.400.500.500
|
| Concept/Terms |
Receptors, Dopamine D4- Receptors, Dopamine D4
- D4 Receptors, Dopamine
- Dopamine D4 Receptor
- D4 Receptor, Dopamine
- Dopamine D4 Receptors
- Receptor, Dopamine D4
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Dopamine D4".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Biogenic Amine [D12.776.543.750.670]
- Receptors, Catecholamine [D12.776.543.750.670.300]
- Receptors, Dopamine [D12.776.543.750.670.300.400]
- Receptors, Dopamine D2 [D12.776.543.750.670.300.400.500]
- Receptors, Dopamine D4 [D12.776.543.750.670.300.400.500.500]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Catecholamine [D12.776.543.750.695.150]
- Receptors, Dopamine [D12.776.543.750.695.150.400]
- Receptors, Dopamine D2 [D12.776.543.750.695.150.400.500]
- Receptors, Dopamine D4 [D12.776.543.750.695.150.400.500.750]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Catecholamine [D12.776.543.750.720.330]
- Receptors, Dopamine [D12.776.543.750.720.330.400]
- Receptors, Dopamine D2 [D12.776.543.750.720.330.400.500]
- Receptors, Dopamine D4 [D12.776.543.750.720.330.400.500.500]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Dopamine D4".
This graph shows the total number of publications written about "Receptors, Dopamine D4" by people in this website by year, and whether "Receptors, Dopamine D4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 2 | 2 |
| 2011 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Dopamine D4" by people in Profiles.
-
Kleinjan M, Engels RC, DiFranza JR. Parental smoke exposure and the development of nicotine craving in adolescent novice smokers: the roles of DRD2, DRD4, and OPRM1 genotypes. BMC Pulm Med. 2015 Oct 08; 15:115.
-
S?nchez-Mora C, Ribas?s M, Casas M, Bay?s M, Bosch R, Fern?ndez-Castillo N, Brunso L, Jacobsen KK, Landaas ET, Lundervold AJ, Gross-Lesch S, Kreiker S, Jacob CP, Lesch KP, Buitelaar JK, Hoogman M, Kiemeney LA, Kooij JJ, Mick E, Asherson P, Faraone SV, Franke B, Reif A, Johansson S, Haavik J, Ramos-Quiroga JA, Cormand B. Exploring DRD4 and its interaction with SLC6A3 as possible risk factors for adult ADHD: a meta-analysis in four European populations. Am J Med Genet B Neuropsychiatr Genet. 2011 Jul; 156B(5):600-12.
-
Campbell BC, Dreber A, Apicella CL, Eisenberg DT, Gray PB, Little AC, Garcia JR, Zamore RS, Lum JK. Testosterone exposure, dopaminergic reward, and sensation-seeking in young men. Physiol Behav. 2010 Mar 30; 99(4):451-6.
-
Smith AK, Mick E, Faraone SV. Advances in genetic studies of attention-deficit/hyperactivity disorder. Curr Psychiatry Rep. 2009 Apr; 11(2):143-8.
-
Monuteaux MC, Seidman LJ, Faraone SV, Makris N, Spencer T, Valera E, Brown A, Bush G, Doyle AE, Hughes S, Helliesen M, Mick E, Biederman J. A preliminary study of dopamine D4 receptor genotype and structural brain alterations in adults with ADHD. Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 05; 147B(8):1436-41.
-
Golimbet VE, Lebedeva IS, Gritsenko IK, Korovaitseva GI, Alfimova MV, Lezheiko TV, Abramova LI, Kaleda VG, Ebshtein RP, Rogaev EI. [A study of some genes related to serotoninergic and dopaminergic systems and auditory evoked-potentials (P300) in patients with schizophrenia and spectrum disorders and their first-degree relatives]. Zh Nevrol Psikhiatr Im S S Korsakova. 2005; 105(10):35-41.
-
Castellanos FX, Lau E, Tayebi N, Lee P, Long RE, Giedd JN, Sharp W, Marsh WL, Walter JM, Hamburger SD, Ginns EI, Rapoport JL, Sidransky E. Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: genetic and brain morphometric analyses. Mol Psychiatry. 1998 Sep; 3(5):431-4.